Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotrophic Lateral Sclerosis
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
Source: apnews.com
Hand Held Dynamometry News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Hand Held Dynamometry. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Hand Held Dynamometry Today - Breaking & Trending Today
Biogen Inc.: Biogen and Ionis Announce Topline Phase 1 Study Results of Investigational Drug in C9orf72 Amyotrophic Lateral Sclerosis
BIIB078, an investigational antisense oligonucleotide for C9orf72-associated amyotrophic lateral sclerosis (ALS), did not show clinical benefit; clinical program will be discontinuedBiogen and Ionis remain
Source: finanznachrichten.de